Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population

European Journal of Dermatology

Volumn 12, Issue 6, 2002, Pages 540-542

  Borgiani, Paola ^a   Vallo, Laura ^a   D'Apice, Maria Rosaria ^a   Giardina, Emiliano ^a   Pucci, Sabina ^a   Capon, Francesca ^a   Nisticò, Steven ^a   Chimenti, Sergio ^a   Pallone, Francesco ^a   Novelli, Giuseppe ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CARD15; Crohn's Disease; Genetic susceptibility; NOD2; Psoriasis; Pyrosequencing

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ITALY; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PSORIASIS;

ALLELES; BASE SEQUENCE; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ITALY; LINKAGE (GENETICS); MALE; MOLECULAR SEQUENCE DATA; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROBABILITY; PSORIASIS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX;

EID: 0036861693     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Nevitt GJ, Hutchinson PE. Psoriasis in the community: Prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 1996; 135: 533-7.
2. Barker JN. The pathophysiology of psoriasis. Lancet 1991; 338: 227-30.
3. Hellgren I. Psoriasis: The Prevalence in Sex Age and Occupational Groups in Total Population in Sweden: Morphology, Inheritance and Association with Other Skin and Rheumatic Diseases. Stockolm: Amqvist and Wiksell, 1967.
4. Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica (Basel) 1974; 148: 1-18.
5. Capon F, Dallapiccola B, Novelli G. Advances in the search for psoriasis susceptibility genes. Mol Genet Metabol 2000; 71: 250-5.
6. Nair RP, Henseler T, Jenisch S, et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20q) by genome wide scan. Hum Mol Genet 1997; 6: 1349-56.
7. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-6.
8. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
9. Hampe J, Cuthbert A, Croucher PJP, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357: 1925-8.
10. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845-57.
11. Vavassori P, Borgiani P, D'Apice MR, et al. 3020insC mutation within the NOD2 gene in Crohn's disease: Frequency and association with clinical pattern in an Italian population. Dig Liver Dis 2002; 34: 153.
12. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD 15 mutations in Blau syndrome. Nat Genet 2001; 29: 19-20.
13. Nair RP, Stuart P, Ogura Y, et al. Lack of association between NOD2 3020insC frameshift mutation and psoriasis. J Invest Dermatol 2000; 117: 1671-2.
14. Ronaghi M, Uhlen M, Nyren P. A sequencing method based on realtime pyrophosphate. Science 1998; 281: 363-5.